Main Menu
Menu

Fact Checks

Publish Date
BlogFact Checks
Fact Check: The ETHIC Act Targets a Problem That Doesn’t Exist

Congress is considering a bill, the Eliminating Thickets to Increase Competition (ETHIC) Act, that would undermine innovation by preventing patent owners from...

BlogFact Checks
Fact Check: Limiting Injunctive Relief Harms, Not Helps, Inventors

Among the most consequential foreign policy developments is the European Union’s (EU’s) consideration of policies that could limit access to injunctive relief....

BlogFact Checks
Fact Check: The NO FAKES Act Won’t Stifle Innovation — It Will Protect It

The rapid advancement of artificial intelligence has given creators and inventors new technological tools to enhance their work — but it has...

BlogFact Checks
Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”

Former Federal Trade Commission Chair Lina Khan recently appeared on The Weekly Show with Jon Stewart, where their discussion revived familiar tropes...

BlogFact Checks
Fact Check: What Critics Get Wrong About the Patent Eligibility Restoration Act

A coalition of anti-patent groups — including the R Street Institute, the Electronic Frontier Foundation, Public Knowledge, and others — recently sent...

BlogFact Checks
Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.

In a recent STAT article, I-MAK CEO Tahir Amin argues that abuses of the patent system are leading to higher drug costs....

BlogFact Checks
Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”

Several academic authors recently published an article in Health Affairs Forefront advising policymakers in Congress and at the USPTO on the best...

BlogFact Checks
Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards

The word “open” has become increasingly misused in the world of technology standards. In policy and antitrust terms, an open standard is...

Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology
Fact ChecksResources
Infographics & Fact Sheets
Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences
BlogFact Checks
Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry

Myths about how patent rights affect competition within the drug industry remain a pressing issue for innovators. Although strong patents play a...

BlogFact Checks
Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.

In recent months, federal policymakers have renewed calls for “Most-Favored-Nation” (MFN) drug pricing, which would tie the price of medicines in the...

Blog:

Blog, Fact Checks:

Fact Check: The ETHIC Act Targets a Problem That Doesn’t Exist,

04/17/2026
Blog:

Blog, Fact Checks:

Fact Check: Limiting Injunctive Relief Harms, Not Helps, Inventors,

03/20/2026
Blog:

Blog, Fact Checks:

Fact Check: The NO FAKES Act Won’t Stifle Innovation — It Will Protect It,

02/27/2026
Blog:

Blog, Fact Checks:

Fact Check: Debunking The Myth of “Evergreening” and “Patent Thicketing”,

01/16/2026
Blog:

Blog, Fact Checks:

Fact Check: What Critics Get Wrong About the Patent Eligibility Restoration Act,

12/19/2025
Blog:

Blog, Fact Checks:

Fact Check: Weakening the patent system won’t lower prices for patients. It would undermine medical progress.,

12/04/2025
Blog:

Blog, Fact Checks:

Fact Check: The Data Doesn’t Support the Existence of So-Called Patent “Thickets”,

11/21/2025
Blog:

Blog, Fact Checks:

Fact Check: The Myth of So-Called “Royalty Free” and “Open” Standards,

10/30/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Software and Technology,

09/25/2025
Resources:

Fact Checks, Resources:

Myths vs. Facts: The Patent Eligibility Restoration Act (PERA) – Diagnostics and Life Sciences,

09/25/2025
Blog:

Blog, Fact Checks:

Fact Check: Separating Fact From Fiction in Recent FTC/DOJ Listening Sessions on Patents in the Drug Industry,

09/19/2025
Blog:

Blog, Fact Checks:

Fact Check: IP Protections Power the U.S. Innovation Economy. MFN Would Undermine this System.,

08/14/2025
Scroll to Top